Unicycive Therapeutics, Inc. - UNCY

Ownership (Schedule 13D / 13G) · latest 50 filings · Back to all files
Visible: 0
Filed Form Reporting person Percent Shares SEC
Jul 08, 2026 SCHEDULE 13G/A Integrated Core Strategies (US) LLC 0.8% 205,529 View
Jul 08, 2026 SCHEDULE 13G/A Millennium Management LLC 1.0% 271,456 View
Jul 08, 2026 SCHEDULE 13G/A Millennium Group Management LLC 1.0% 271,456 View
Jul 08, 2026 SCHEDULE 13G/A Israel A. Englander 1.0% 271,456 View
May 15, 2026 SCHEDULE 13G/A RA Capital Management, L.P. 9.9% 2,801,082 View
May 15, 2026 SCHEDULE 13G/A Peter Kolchinsky 9.9% 2,801,082 View
May 15, 2026 SCHEDULE 13G/A Rajeev Shah 9.9% 2,801,082 View
May 15, 2026 SCHEDULE 13G/A RA Capital Healthcare Fund, L.P. 9.9% 2,801,082 View
Feb 17, 2026 SCHEDULE 13G/A RA Capital Management, L.P. 9.9% 2,385,279 View
Feb 17, 2026 SCHEDULE 13G/A Peter Kolchinsky 9.9% 2,385,279 View
Feb 17, 2026 SCHEDULE 13G/A Rajeev Shah 9.9% 2,385,279 View
Feb 17, 2026 SCHEDULE 13G/A RA Capital Healthcare Fund, L.P. 9.9% 2,385,279 View
Feb 13, 2026 SCHEDULE 13G/A Nantahala Capital Management, LLC 9.99% 2,281,040 View
Feb 13, 2026 SCHEDULE 13G/A Wilmot B. Harkey 9.99% 2,281,040 View
Feb 13, 2026 SCHEDULE 13G/A Daniel Mack 9.99% 2,281,040 View
Feb 10, 2026 SCHEDULE 13G/A Octagon Capital Advisors LP 4.7% 1,000,000 View
Feb 10, 2026 SCHEDULE 13G/A Octagon Investments Master Fund LP 3.0% 650,000 View
Feb 10, 2026 SCHEDULE 13G/A Octagon Biotech Opportunities Fund I LP 1.7% 350,000 View
Feb 10, 2026 SCHEDULE 13G/A Ting Jia 4.7% 1,000,000 View
Percent = "% of class represented by amount beneficially owned" for this reporting person in the filed 13D/13G. Shares = reported beneficial ownership amount for the same row (not portfolio shares from 13F). Amendments (/A) can repeat the same holder over time, so rows should not be summed. Extraction is best-effort from filing text and can be missing or noisy; verify exact figures via the SEC link in each row.